Due to low levels, however, measuring endogenous LRRK2 Ser1292 has been technically challenging and only robustly detected in overexpression models or in urine following exosome enrichment in PD patients carrying the G2019S mutation or idiopathic PD27,28. Here, LRRK2 is linked to Parkinson disease.